Ing. Daniel Buša

Research specialist, Department of Internal Medicine, Hematology and Oncology

correspondence Address:
Jihlavská 340/20, 625 00 Brno

office: bldg. F01B2/156
Kamenice 126/3
625 00 Brno

Show on the map

phone:	+420 549 49 5437
e‑mail:

social and academic networks:

Basic information

Type

Total number of publications: 14

2024

ANALYSIS OF ALTERNATIVE THERAPEUTIC OPTIONS FOR ACUTE MYELOID LEUKEMIA PATIENTS RESISTANT TO VENETOCLAX BASED ON DRUG SCREENING AND EXPRESSION PROFILING

STYLIANOU Filio LADUNGOVÁ Adriana HÝL Jan BUŠA Daniel ČULEN Martin WEINBERGEROVÁ Barbora MAYER Jiří ŠMÍDA Michal

Conference abstract

Year: 2024, type: Conference abstract
IDENTIFICATION OF CHRONIC MYELOID LEUKEMIA STEM CELLS AT DIAGNOSIS AND EARLY FOLLOW-UP

ČULEN Martin ROMŽOVÁ Marianna SMITALOVÁ Dagmar LOJA Tomáš BUŠA Daniel VENGLÁŘ Ondřej HERUDKOVÁ Zdeňka BORSKÝ Marek TAUŠ Petr REIGL Tomáš PLEVOVÁ Karla ŠMEJKAL Jiří ŽÁČKOVÁ Daniela STEJSKAL L. RÁČIL Zdeněk MAYER Jiří

Conference abstract

Year: 2024, type: Conference abstract
ROBUST ACUTE MYELOID LEUKEMIA ENGRAFTMENT IN HUMANIZED SCAFFOLDS USING INJECTABLE BIOMATERIALS AND INTRAVENOUS XENOTRANSPLANTATION

BUŠA Daniel HERUDKOVÁ Zdeňka HÝL Jan VLAŽNÝ Jakub SOKOL F. MATULOVÁ Květoslava FOLTA A. HYNŠT Jakub VOJTOVÁ Lucy KŘEN Leoš REPKO Martin RÁČIL Zdeněk MAYER Jiří ČULEN Martin

Conference abstract

Year: 2024, type: Conference abstract

2023

AML engraftment in humanized ossicles is not governed by biomaterial selection.

ČULEN Martin BUŠA Daniel HERUDKOVÁ Zdeňka HÝL Jan VLAŽNÝ Jakub MATULOVÁ Květoslava REPKO Martin VOJTOVÁ Lucy MAYER Jiří

Conference abstract

Year: 2023, type: Conference abstract
Biomaterial selection does not affect AML engraftment in humanized ossicles.

ČULEN Martin LOJA Tomáš BUŠA Daniel HERUDKOVÁ Zdeňka HÝL Jan VLAŽNÝ Jakub LIŠKOVÁ K. REPKO Martin VOJTOVÁ Lucy MAYER Jiří

Conference abstract

Year: 2023, type: Conference abstract
Inhibition of acute myeloid leukemia using palbociclib and ponatinib in a patient-derived xenograft model.

BUŠA Daniel ČULEN Martin LOJA Tomáš JEŽÍŠKOVÁ Ivana FOLTA Adam MAYER Jiří

Conference abstract

Year: 2023, type: Conference abstract

2022

. Drug repurposing for venetoclax-resistant acute myeloid leukemia.

LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract
Acute myeloid leukemia suppression by palbociclib and ponatinib in patient-derived xenograft

BUŠA Daniel ČULEN Martin JEŽÍŠKOVÁ Ivana FOLTA Adam MAYER Jiří

Conference abstract

Year: 2022, type: Conference abstract
Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML

LODHI Yusuf LADUNGOVÁ Adriana BUŠA Daniel PESCHELOVÁ Helena ČULEN Martin ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract
Identification of novel therapeutic options for venetoclax-resistant AML cells through drug repurposing

LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract